Utah Medical Products | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. Rowe Price Investment Management, Inc.(9.4%),T. ROWE PRICE SMALL-CAP VALUE FUND, INC.(6.6%)
猶他醫療產品 | SC 13G:超過5%持股股東披露文件-T. Rowe Price Investment Management, Inc.(9.4%),T. ROWE PRICE SMALL-CAP VALUE FUND, INC.(6.6%)
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。